Utah Medical Products Statistics
Total Valuation
UTMD has a market cap or net worth of $212.50 million. The enterprise value is $121.39 million.
Important Dates
The last earnings date was Thursday, April 23, 2026, before market open.
| Earnings Date | Apr 23, 2026 |
| Ex-Dividend Date | Mar 17, 2026 |
Share Statistics
UTMD has 3.18 million shares outstanding. The number of shares has decreased by -6.35% in one year.
| Current Share Class | 3.18M |
| Shares Outstanding | 3.18M |
| Shares Change (YoY) | -6.35% |
| Shares Change (QoQ) | -0.39% |
| Owned by Insiders (%) | 7.18% |
| Owned by Institutions (%) | 61.58% |
| Float | 2.76M |
Valuation Ratios
The trailing PE ratio is 19.75.
| PE Ratio | 19.75 |
| Forward PE | n/a |
| PS Ratio | 5.56 |
| Forward PS | n/a |
| PB Ratio | 1.77 |
| P/TBV Ratio | 1.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 11.19 |
| EV / Sales | 3.23 |
| EV / EBITDA | 8.01 |
| EV / EBIT | 9.98 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 28.64, with a Debt / Equity ratio of 0.00.
| Current Ratio | 28.64 |
| Quick Ratio | 25.97 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.14% and return on invested capital (ROIC) is 29.35%.
| Return on Equity (ROE) | 9.14% |
| Return on Assets (ROA) | 6.16% |
| Return on Invested Capital (ROIC) | 29.35% |
| Return on Capital Employed (ROCE) | 10.07% |
| Weighted Average Cost of Capital (WACC) | 6.16% |
| Revenue Per Employee | $246,921 |
| Profits Per Employee | $71,375 |
| Employee Count | 152 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 1.82 |
Taxes
In the past 12 months, UTMD has paid $2.58 million in taxes.
| Income Tax | 2.58M |
| Effective Tax Rate | 19.24% |
Stock Price Statistics
The stock price has increased by +27.44% in the last 52 weeks. The beta is 0.35, so UTMD's price volatility has been lower than the market average.
| Beta (5Y) | 0.35 |
| 52-Week Price Change | +27.44% |
| 50-Day Moving Average | 65.62 |
| 200-Day Moving Average | 60.75 |
| Relative Strength Index (RSI) | 50.95 |
| Average Volume (20 Days) | 12,394 |
Short Selling Information
The latest short interest is 137,091, so 4.31% of the outstanding shares have been sold short.
| Short Interest | 137,091 |
| Short Previous Month | 131,281 |
| Short % of Shares Out | 4.31% |
| Short % of Float | 4.96% |
| Short Ratio (days to cover) | 9.43 |
Income Statement
In the last 12 months, UTMD had revenue of $37.53 million and earned $10.85 million in profits. Earnings per share was $3.38.
| Revenue | 37.53M |
| Gross Profit | 21.75M |
| Operating Income | 12.17M |
| Pretax Income | 13.43M |
| Net Income | 10.85M |
| EBITDA | 15.15M |
| EBIT | 12.17M |
| Earnings Per Share (EPS) | $3.38 |
Full Income StatementBalance Sheet
The company has $87.41 million in cash and $210,000 in debt, giving a net cash position of $87.20 million or $27.39 per share.
| Cash & Cash Equivalents | 87.41M |
| Total Debt | 210,000 |
| Net Cash | 87.20M |
| Net Cash Per Share | $27.39 |
| Equity (Book Value) | 120.37M |
| Book Value Per Share | 37.81 |
| Working Capital | 96.87M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.98M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 57.94%, with operating and profit margins of 32.42% and 28.91%.
| Gross Margin | 57.94% |
| Operating Margin | 32.42% |
| Pretax Margin | 35.79% |
| Profit Margin | 28.91% |
| EBITDA Margin | 40.36% |
| EBIT Margin | 32.42% |
| FCF Margin | n/a |